Condition: Rheumatoid Arthritis
Interventions: Biological: MK-8808; Biological: Rituximab; Drug: methotrexate
Sponsor: Merck
Recruiting - verified August 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.